IL6 and neoplasm: Given prior evidence linking ER stress, particularly activation of the IRE1α pathway, to increased IL-6 secretion in other cell types (e.g., glial cells under ischemic conditions)56–58, we investigated whether a similar mechanism drives IL-6 production in NSCLC tumor cells.